{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T22:39:16Z","timestamp":1774478356144,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":5147,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1093\/bja\/aeg262","type":"journal-article","created":{"date-parts":[[2003,10,22]],"date-time":"2003-10-22T01:36:36Z","timestamp":1066786596000},"page":"744-747","source":"Crossref","is-referenced-by-count":9,"title":["Anaesthetic management of coronary artery bypass grafting in a patient with central core disease and susceptibility to malignant hyperthermia on statin therapy"],"prefix":"10.1016","volume":"91","author":[{"given":"R.R.","family":"Johi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J.","family":"Halsall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/bja\/aeg262_bib1","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/brain\/79.4.610","article-title":"A new congenital non-progressive myopathy","volume":"79","author":"Shy","year":"1956","journal-title":"Brain"},{"key":"10.1093\/bja\/aeg262_bib2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/343562a0","article-title":"Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12\u201313.2","volume":"343","author":"McCarthy","year":"1990","journal-title":"Nature"},{"key":"10.1093\/bja\/aeg262_bib3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0888-7543(91)90461-M","article-title":"Evidence for linkage of the central core disease locus to the proximal long arm of human chromosome 19","volume":"10","author":"Kausch","year":"1991","journal-title":"Genomics"},{"key":"10.1093\/bja\/aeg262_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D","article-title":"Ryanodine receptor mutations in malignant hyperthermia and central core disease","volume":"15","author":"McCarthy","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1093\/bja\/aeg262_bib5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0960-8966(01)00202-4","article-title":"Identification and functional characterisation of a novel ryanodine receptor mutation causing malignant hyperthermia in North American and South American families","volume":"11","author":"Sambuughin","year":"2001","journal-title":"Neuromuscul Disord"},{"key":"10.1093\/bja\/aeg262_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1086\/321270","article-title":"Single-amino-acid deletion in the RYR1 gene, associated with malignant hyperthermia susceptibility and unusual contraction phenotype","volume":"69","author":"Sambuughin","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1093\/bja\/aeg262_bib7","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/hmg\/10.25.2879","article-title":"Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis","volume":"10","author":"Tilgen","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1093\/bja\/aeg262_bib8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/bja\/88.4.508","article-title":"Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees","volume":"88","author":"Davis","year":"2002","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aeg262_bib9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/bja\/56.11.1267","article-title":"A protocol for the investigation of malignant hyperpyrexia susceptibility","volume":"56","author":"European Malignant Hyperpyrexia Group","year":"1984","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aeg262_bib10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bja\/86.2.166","article-title":"A breakthrough in the genetic diagnosis of malignant hyperthermia","volume":"86","author":"Robinson","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aeg262_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","article-title":"Guidelines for the molecular testing of susceptibility to malignant hyperthermia","volume":"86","author":"Urwyler","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aeg262_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF03007948","article-title":"Management of a malignant hyperthermia patient during cardiopulmonary bypass","volume":"29","author":"Byrick","year":"1982","journal-title":"Can Anaesth Soc J"},{"key":"10.1093\/bja\/aeg262_bib13","first-page":"229","article-title":"The safety of dantrolene in a patient with a severe cardiomyopathy requiring a heart transplant","volume":"85","author":"Koehntop","year":"1987","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aeg262_bib14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1345\/aph.1A289","article-title":"FDA adverse event reports on statin-associated rhabdomyolysis","volume":"36","author":"Omar","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1093\/bja\/aeg262_bib15","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1345\/aph.10228","article-title":"Rhabdomyolysis and HMG-CoA reductase inhibitors. (Review)","volume":"35","author":"Omar","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1093\/bja\/aeg262_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/art.11013","article-title":"Rhabdomyolysis and myalgia associated with anticholesterolemic treatment as potential signs of malignant hyperthermia susceptibility","volume":"49","author":"Guis","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1093\/bja\/aeg262_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1742-1241.1992.tb10274.x","article-title":"Aprotinin: its role in modifying perioperative blood loss","volume":"46","author":"Boscoe","year":"1992","journal-title":"Br J Clin Pract"},{"key":"10.1093\/bja\/aeg262_bib18","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S1010-7940(01)01016-8","article-title":"Aprotinin reduces postoperative bleeding and the need for blood products in thoracic surgery: results of a randomized double-blind study","volume":"20","author":"Bedirhan","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1093\/bja\/aeg262_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1054\/bjom.2001.0664","article-title":"Aprotinin reduces blood loss and need for transfusion in orthognathic surgery","volume":"39","author":"Stewart","year":"2001","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1093\/bja\/aeg262_bib20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/jlts.2001.27086","article-title":"Aprotinin reduces red blood transfusion in orthoptic liver transplantation: a prospective randomized double blind study","volume":"7","author":"Findlay","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1093\/bja\/aeg262_bib21","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1097\/00007632-200105150-00012","article-title":"The efficacy of antifibrinolytic in the reduction of blood loss during complex adult reconstructive spine surgery","volume":"26","author":"Urban","year":"2001","journal-title":"Spine"},{"key":"10.1093\/bja\/aeg262_bib22","first-page":"803","article-title":"Prior hypothermia attenuates malignant hyperthermia in susceptible swine","volume":"82","author":"Iaizzo","year":"1996","journal-title":"Anesth Analg"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217363146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217363146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bja\/article-pdf\/91\/5\/744\/706090\/aeg262.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T03:33:28Z","timestamp":1704944008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091217363146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0007091217363146"],"URL":"https:\/\/doi.org\/10.1093\/bja\/aeg262","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}